Navigation Links
Global Health Project targets reducing AIDS among India's adolescents
Date:9/12/2007

Tampa, FL (Sept. 12, 2007) -- The University of South Floridas global health initiative to help India build an infrastructure to fight AIDS has been strengthened with a $1.36-million research training grant from the National Institutes of Health.

USF Health received the five-year grant Sept. 11 from the NIHs Fogarty International Center to create an interdisciplinary training program focused on the biomedical, behavioral, cultural and ethical aspects of detecting, treating and preventing HIV/AIDS among adolescents in India. USF will partner with Vadodara Medical College in Gujarat, India, to teach Indian physicians, scientists, nurses, and other health professionals how to conduct and evaluate community-based HIV clinical studies for this vulnerable population.

This program represents another exciting opportunity for USF to shine in the international health arena and to broaden the scope of our HIV research and training partnerships in India, said USF pediatrician Dr. Patricia Emmanuel, principal investigator for the project. It will enhance new knowledge in the area of adolescent health and benefit USF and the local communities in India.

India ranks second worldwide, following South Africa, in the number of HIV and AIDS cases. In some places in India, half of all new HIV infections occur in adolescents and young adults. Young people are at greater risk for HIV for several reasons, including girls increased biological susceptibility and a tendency for risky behaviors like unprotected sex and IV drug use, Emmanuel said.

India has made some significant inroads in committing resources to the pressing public health problem of AIDS. But, a recent article in the New England Journal of Medicine reports that to curb the spread of the HIV epidemic, the developing nation must meet several challenges, including increasing the number of patients treated, improving the monitoring of therapy, caring for patients with tuberculosis coinfection, and reducing the stigma and discrimination associated with AIDS.

We expect to train more home-grown investigators who can confront these barriers by addressing research questions specific to the HIV epidemic in India, Emmanuel said.

The new grant the latest of three NIH Fogarty International awards to USF faculty -- was spearheaded by USF Healths Signature Interdisciplinary Program in Allergy, Immunology and Infectious Disease (SPAIID) and the USF-India Center for Health, HIV/AIDS Research and Training (CHART-India). Emmanuel will work with co-principal investigators Dr. Shyam Mohapatra and Dr. Eknath Naik.

The grant will expand the existing HIV infrastructure built by CHART-India. Since 1999, USF medical and public health faculty have established several CHART centers across India to care for people with HIV/AIDS, train staff and conduct research.

The Fogarty project will draw upon the expertise of USFs nationally-recognized Tampa Bay Adolescent Medicine Trials Unit. The unit, directed by Emmanuel, is one of 15 NIH-funded clinical sites across the country providing comprehensive services to HIV-infected adolescents. Emmanuel oversees a large team of researchers and clinicians who work with both adolescents and children -- educating youth at high risk for HIV in an effort to prevent AIDS, offering new treatments, and evaluating barriers to clinical trial enrollment and retention.

This prestigious grant is a national recognition of our strategic efforts to create an effective network for the globalization of translational and clinical research, said Dr. Abdul S. Rao, senior associate vice president for USF Health. It also underscores the efforts of our interdisciplinary signature program in allergy, immunology and infectious diseases, which was established last year to facilitate such activities.


'/>"/>

Contact: Anne DeLotto Baier
abaier@health.usf.edu
813-974-3300
University of South Florida Health
Source:Eurekalert

Related medicine news :

1. Skin Cancer Research To Go Global
2. Dementia - a global problem
3. Obesity a global problem
4. Suggestions to reduce global heart disease burden
5. Drop in global deaths from measles
6. First global SARS meet opens
7. SARS-Free Taiwan to Mark End Phase of Global Fight
8. Prevent Global Warming by Becoming A Vegetarian
9. India To March Ahead in The Global HealthCare Competition
10. Global Outbreak Of Bird Flu Warning By Chinese Scientist
11. TWO India Doctors Listed in TIME for Contribution to Global Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 2017 , ... The Center for Autism and Related Disorders ... Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. The events ... films in an environment that accommodates their unique needs. , Launched in January, ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... ... February 22, 2017 , ... When it came ... contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. January’s grand ... recently invested $51 million to purchase and renovate the 185,000 square-foot office complex, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... The Waismann ... the thousands of individuals who have recently fallen victim to America’s opioid epidemic. Now, ... Orange County, California, where they are free from the shame, stigma, and harmful ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... to fewer trips the emergency room, fewer hospital admissions, and better blood pressure ... Managed Care® (AJMC®) finds. The study can be found here . , ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Prosthetic Devices Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 9.2% over the next ... industry report analyzes the market estimates and forecasts for all the ...
(Date:2/23/2017)... 23, 2017 MabVax Therapeutics Holdings, ... development company, announces that it has received notice ... authorizing the initiation a Phase I clinical trial ... cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s ... to initiate the phase I clinical trial in ...
(Date:2/23/2017)... , Feb. 22, 2017 Orthopedic ... implant demand, as aging demographic patterns lead to ... Implants for sports- and exercise-related injuries, chronic back ... will lead sales gains. The future of medical ... addresses the following questions and more: - ...
Breaking Medicine Technology: